Partnerships & Mergers

Under the agreement, Sheba physicians will receive early access to new healthcare models before their wider release, while the partnership will also expand research collaboration between the two organizations.

Under the agreement, SGH-referred healthcare practitioners will have access to DataFlow’s range of services, including Premium PSV, VIP Assist, Document Concierge, licensing and credentialing support, digital footprint checks and Prometric nursing exam training.

The partnership comes as Egypt seeks to attract more patients from Arab and African markets by capitalising on its healthcare advantages.

Following the transaction, former Kira shareholders will own nearly 50% of the combined company, new private financing investors will hold slightly more than 43%, and existing Jasper shareholders will retain almost 7%.

Through its membership, PTx will gain access to longitudinal health data and biosamples from people living with IBD, with personal identifying information removed.

Through this collaboration, both organisations will work to improve patient care by supporting healthcare professionals with access to the latest medical knowledge and best practices.

The assistance forms part of a wider U.S.-Madagascar health partnership established under the bilateral Global Health Memorandum of Understanding (MOU) signed in December 2025.

The partnership combines GCLS’s expertise as the world’s first higher education institution dedicated exclusively to longevity science with GMU’s academic resources and Thumbay Healthcare’s extensive clinical network across the region.

Under the agreement, researchers will gain access to an integrated platform that combines Evogene’s AI-powered computational chemistry engine, ChemPass AI, with the BCDD’s laboratory infrastructure and drug discovery expertise.

Under the agreement, Novo Nordisk will internally assess Vivani’s investigational NPM-139 implant, which utilizes the company’s proprietary NanoPortal technology to deliver semaglutide continuously over extended periods through a miniature subdermal device.